Human Rabies Vaccine Market - Global Trend and Growth Outlook to 2030
                     HUMAN RABIES VACCINE 
MARKET - GLOBAL TREND AND 
GROWTH OUTLOOK TO 2030
POWERED BY HTF MARKET INTELLIGENCE CONSULTING PVT. LTD.
Market Definition & 
Scope
The human rabies vaccine is a medical product specifically designed to prevent people from 
becoming infected with the rabies virus. Rabies is a deadly viral disease spread through the 
saliva of infected animals, mainly dogs, bats, and certain wild animals. The vaccine works by 
stimulating the immune system to produce antibodies against the rabies virus, which provides 
immunity after exposure. This vaccination is very important for people who are at high risk of 
exposure to rabies, such as veterinarians, and animal caretakers. In addition, getting 
vaccinated against rabies usually involves a few shots and one needs booster shots based on 
risk level and prior vaccinations.
Since rabies is very serious and almost always deadly once symptoms show, getting 
vaccinated on time is crucial to stop the disease and save lives. Pharmaceutical companies 
make and distribute rabies vaccines worldwide, often working with public health agencies.
REPORTS POWERED BY HTF MARKET INTELLIGENCE CONSULTING PVT. LTD.
Market Keyword by Type
Market Type 6
Chick embryo cells rabies vaccine
5
Vero cell rabies vaccine
4
Human diploid cell vaccine 
(HDCV)
3
Baby hamster kidney (BHK) cells 
rabies vaccine 2
Others
1
0
Type2 Type3 Type4
POWERED BY HTF MARKET INTELLIGENCE CONSULTING PVT. LTD.
Market Keyword by Application
6
By Prophylaxis Type 5
Pre-exposure prophylaxis
4
Post-exposure prophylaxis
3
2
1
0
Category 1 Category 2 Category 3 Category 4
Series 1 Series 2 Series 3
POWERED BY HTF MARKET INTELLIGENCE CONSULTING PVT. LTD.
Key Players
Sanofi 
(France) GlaxoSmit
Other hKline plc (United 
Kingdom)
Some of the key players profiled in 
the study are - Zoetis Inc. - Merck & 
Parsippan Co., Inc. 
y (United (United 
• Sanofi (France) States) States)
• GlaxoSmithKline plc (United 
Kingdom) Boehringe Compani Bharat 
• Merck & Co., Inc. (United States) r es Biotech 
• Bharat Biotech International Limited Ingelheim InternatioInternatio nal 
(India) nal GmbH Limited 
• Cadila Pharmaceuticals (India) (Germany) (India)
• Serum Institute of India Pvt. Ltd 
(India) AstraZenec Cadila 
• Novartis AG (Switzerland) a (United Pharmaceuticals (India)
• AstraZeneca (United Kingdom) Kingdom)
• Boehringer Ingelheim International Novartis Serum AG Institute of 
GmbH (Germany) (Switzerla India Pvt. Ltd 
• Zoetis Inc. - Parsippany (United nd) (India)
States)
POWERED BY HTF MARKET INTELLIGENCE CONSULTING PVT. LTD.
Regions
If opting for the Global version of Human 
Rabies Vaccine Market; then the below 
country analysis would be included:
• North America (the USA, Canada, and Mexico)
• Europe (Germany, France, the United Kingdom, 
Netherlands, Italy, Nordic Nations, Spain, 
Switzerland, and the Rest of Europe)
• Asia-Pacific (China, Japan, Australia, New 
Zealand, South Korea, India, Southeast Asia, and 
the Rest of APAC)
• South America (Brazil, Argentina, Chile, 
Colombia, the Rest of the countries, etc.)
• The Middle East and Africa (Saudi Arabia, United 
Arab Emirates, Israel, Egypt, Turkey, Nigeria, 
South Africa, Rest of MEA)
POWERED BY HTF MARKET INTELLIGENCE CONSULTING PVT. LTD.
Report:
Get free access to report link @ 
https://www.htfmarketintelligence.com/report/global-human-rabies-vaccine-market 
POWERED BY HTF MARKET INTELLIGENCE CONSULTING PVT. LTD.
Contact Us
Contact Us: 
Nidhi Bhawsar (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Phone: +15075562445
[email protected]
Connect with us on LinkedIn | Facebook | Twitter
POWERED BY HTF MARKET INTELLIGENCE CONSULTING PVT. LTD.